United States · FDA National Drug Code directory
Sacubitril and Valsartan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82293-029_4d34c331-a1f9-937a-e063-6294a90a66b7
- Product NDC
- 82293-029
- Form
- TABLET, FILM COATED
- Composition / generic term
- Sacubitril and Valsartan
- Labeler
- Novugen Pharma (USA) LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250716
- Source listing expiry
- 20271231
Source-listed ingredients
- SACUBITRIL — 97 mg/1
- VALSARTAN — 103 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, FILM COATED in 1 BOTTLE (82293-029-10) · 82293-029-10
- 180 TABLET, FILM COATED in 1 BOTTLE (82293-029-20) · 82293-029-20
- 100 BLISTER PACK in 1 BOX, UNIT-DOSE (82293-029-30) / 10 TABLET, FILM COATED in 1 BLISTER PACK (82293-029-31) · 82293-029-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →